This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Amorepacific Corporation. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: The Innovative Contributions of Sung Il Kim
Introduction
Sung Il Kim is a notable inventor based in Yangju-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have therapeutic effects on inflammatory and immunological disorders.
Latest Patents
One of his key patents is focused on 2-cyclopenten-1-one oxime derivatives. These derivatives are represented by Formula (I) and are known to inhibit the production of TNF-α or PDE4. This innovation shows promise in treating various inflammatory or immunological disorders mediated through TNF-α or PDE4. Sung Il Kim holds 1 patent related to this groundbreaking work.
Career Highlights
Sung Il Kim is currently employed at Amorepacific Corporation, a leading company in the beauty and cosmetics industry. His work at Amorepacific allows him to apply his innovative ideas in a practical setting, contributing to the development of new therapeutic solutions.
Collaborations
Throughout his career, Sung Il Kim has collaborated with talented individuals such as Yeonjoon Kim and Sun-Young Kim. These collaborations have fostered a creative environment that encourages the exchange of ideas and enhances the innovation process.
Conclusion
Sung Il Kim's contributions to the field of pharmaceuticals, particularly through his patent on 2-cyclopenten-1-one oxime derivatives, highlight his role as an influential inventor. His work continues to pave the way for advancements in treating inflammatory and immunological disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile